Iliac Stent Market Companies
- Abbott Laboratories
- Alvimedica
- B. Braun SE
- Becton, Dickinson and Company
- Biotronik SE & Co KG
- Boston Scientific Corporation
- Cook Medical
- Getinge AB
- iVascular
- Medtronic Plc
- Terumo Corporation
- W. L. Gore & Associates, Inc.
Recent News:
- The results of the one-year BIONETIC-I research, published in May 2024, revealed that BIOTRONIK's Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System is both safe and effective for treating the iliac artery. New findings presented at LINC 2024 back up the use of thin-strut cobalt chromium stents in calcified iliac lesions. The BIONETIC-I findings indicate that the Dynetic-35 stent is safe and effective in severely calcified lesions, which is crucial when treating iliac arteries.
- Philips introduced the Duo Venous Stent System in June 2024 to treat symptomatic venous outflow obstruction. Following FDA premarket approval, the Sanger Heart & Vascular Institute at Atrium Health treated the first patient with the novel implantable medical device. The Duo Venous Stent System, created for the unique requirements of venous architecture and blockages, comprises two stents of differing sizes: Duo Hybrid and Duo Extend. Duo Hybrid is a novel integrated design that integrates multiple zones with varying mechanical properties into a single stent. These two stents are meant to work together to lessen the danger of stent fracture and corrosion and allow for stent implantation in caudal veins with smaller diameters.